| 摘要 |
<p>The present invention relates to a group of fusion proteins primarily consisting of a hormone peptide with lower molecular weight and a modulator protein, which is characterized by specially killing the recipient cells expressing the peptide with lower molecular weight. Thus, it is potentially useful in treatment of various of disorder.</p> |
